Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US [PDF]
Jeanine Flanigan +3 more
openalex +1 more source
The value of plasma presepsin as a diagnostic and prognostic biomarker for febrile neutropenia in children. [PDF]
Liang J, Luo J, Li G, Li L, Wu J.
europepmc +1 more source
Febrile Neutropenia in the Context of Clozapine-Induced Agranulocytosis (CIA) and Myelodysplastic Syndrome: Importance of a Multidisciplinary Approach. [PDF]
Conchinha AF +4 more
europepmc +1 more source
Bacterial spectrum and antimicrobial resistance patterns in pediatric febrile neutropenia
V. K. Varshney, Rachna Seth
openalex +1 more source
Predicting Bloodstream Infection in Pediatric Post-Transfusion Febrile Neutropenia: Development of a Simple Bedside Risk Score. [PDF]
Lee EJ +4 more
europepmc +1 more source
Evaluation of a Febrile Neutropenia Protocol Implemented at Triage in an Emergency Department. [PDF]
Stramel-Stafford S +4 more
europepmc +1 more source
Institutional Experience with Voriconazole Compared with Liposomal Amphotericin B as Empiric Therapy for Febrile Neutropenia [PDF]
Nadine Shehab +5 more
openalex +1 more source
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany. [PDF]
Steinmetz T +8 more
europepmc +1 more source
Multinational association for supportive care in cancer (MASCC) versus clinical index of stable febrile neutropenia (CISNE): evaluation of predictive performance and clinical utility in patients with febrile neutropenia. [PDF]
Alpar S, Yılmaz S.
europepmc +1 more source

